Transurethral Microwave Thermotherapy for the Treatment of Benign Prostatic Hyperplasia

Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered.
Review Date:	October 28, 2009
Recommendation:	It is recommended that transurethral microwave thermotherapy meets CTAF criteria 1-5 for safety, effectiveness and improvement in health outcomes for the treatment of benign prostatic hyperplasia in men with moderately severe obstructive symptoms and prostate volume of 30-100mL, with no history of prostate procedures, and without prostate cancer.
Decision:	Does Meet CTAF Criteria
Full Assessment:	Download (PDF)

Search Assessments